Literature DB >> 19347612

Introduction: cell-based assays for high-throughput screening.

W Frank An1, Nicola J Tolliday.   

Abstract

Cell-based assays represent approximately half of all high-throughput screens (HTS) currently performed. Here we review the history and status of HTS, and summarize some of the challenges and benefits associated with the use of cell-based assays in HTS, drawing upon themes that will reemerge in subsequent chapters in this book. Approaches for successful experimental design and execution of cell-based HTS are introduced, including strategies for assay development, implementation of primary and secondary screens, and target identification. In doing so, we hope to provide a comprehensive review of the cell-based HTS process and an introduction to the methodologies and techniques described in this book.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347612     DOI: 10.1007/978-1-60327-545-3_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  iPSC-based drug screening for Huntington's disease.

Authors:  Ningzhe Zhang; Barbara J Bailus; Karen L Ring; Lisa M Ellerby
Journal:  Brain Res       Date:  2015-09-30       Impact factor: 3.252

2.  A cell-based high-throughput screen validates the plasmodial surface anion channel as an antimalarial target.

Authors:  Ajay D Pillai; Margaret Pain; Tsione Solomon; Abdullah A B Bokhari; Sanjay A Desai
Journal:  Mol Pharmacol       Date:  2010-01-25       Impact factor: 4.436

3.  High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation.

Authors:  Karl-Johan Leuchowius; Malin Jarvius; Malin Wickström; Linda Rickardson; Ulf Landegren; Rolf Larsson; Ola Söderberg; Mårten Fryknäs; Jonas Jarvius
Journal:  Mol Cell Proteomics       Date:  2009-10-27       Impact factor: 5.911

4.  Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia.

Authors:  Petra Szoleczky; Katalin Módis; Nóra Nagy; Zoltán Dóri Tóth; Douglas DeWitt; Csaba Szabó; Domokos Gero
Journal:  Arch Biochem Biophys       Date:  2011-11-11       Impact factor: 4.013

5.  A screening assay to identify agents that enhance T-cell recognition of human melanomas.

Authors:  Timothy J Haggerty; Ian S Dunn; Lenora B Rose; Estelle E Newton; James T Kurnick
Journal:  Assay Drug Dev Technol       Date:  2011-11-15       Impact factor: 1.738

6.  Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.

Authors:  Hilary A Kenny; Madhu Lal-Nag; Erin A White; Min Shen; Chun-Yi Chiang; Anirban K Mitra; Yilin Zhang; Marion Curtis; Elizabeth M Schryver; Sam Bettis; Ajit Jadhav; Matthew B Boxer; Zhuyin Li; Marc Ferrer; Ernst Lengyel
Journal:  Nat Commun       Date:  2015-02-05       Impact factor: 14.919

Review 7.  Toward the development of podocyte-specific drugs.

Authors:  Jochen Reiser; Vineet Gupta; Andreas D Kistler
Journal:  Kidney Int       Date:  2010-02-03       Impact factor: 10.612

8.  Two-Tiered Selection and Screening Strategy to Increase Functional Enzyme Production in E. coli.

Authors:  Jason T Boock; May Taw; Brian C King; Robert J Conrado; Donna M Gibson; Matthew P DeLisa
Journal:  Methods Mol Biol       Date:  2022

Review 9.  Connecting synthetic chemistry decisions to cell and genome biology using small-molecule phenotypic profiling.

Authors:  Bridget K Wagner; Paul A Clemons
Journal:  Curr Opin Chem Biol       Date:  2009-10-12       Impact factor: 8.822

Review 10.  HTS and hit finding in academia--from chemical genomics to drug discovery.

Authors:  Julie A Frearson; Iain T Collie
Journal:  Drug Discov Today       Date:  2009-09-28       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.